The largest U.S. health insurer, UnitedHealth Group (UNH), delivered a strong third-quarter performance this morning, underscoring its ongoing...
Cannabis stocks were all the hype in late 2020 to early 2021, before fading away for years, but a similar, but smaller, rally seems to be starting up...
UniQure (QURE) surged over 250% today and almost crossed $50 after the company released Phase 1/2 data for AMT-130, which is its experimental gene...
Novo Nordisk (NVO), the Danish pharmaceutical leader, has reclaimed its dominance in the GLP-1 market, driven by strategic agility and innovative...
Circumstances haven’t been easy for UnitedHealth Group (NYSE:UNH) investors. Earlier this year, the insurance giant tanked due to a convergence of...
Although the broader healthcare sector has witnessed significant turbulence throughout this year, some notable players have been making positive...
Let’s cut to the chase: the only reason why people read financial publication articles is to look for an edge in the market. But with the latest...
Tilray Soars on Marijuana Reclassification Buzz—But the Smoke May Clear Fast Tilray (TLRY) shares are on the move again after renewed momentum...
In the pharmaceutical space, there’s nothing hotter than weight-loss drugs. Seemingly every YouTube video features an advertisement on how...
Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D...
Novo Nordisk (NVO) has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly (LLY) plateaued but...
Straight up, I’m not a big fan of trading securities in the pharmaceutical and biotechnology spaces — essentially, anything can happen (and...
Maybe The Wall Street Journal wasn't so "deeply irresponsible" after all. UnitedHealth Group (UNH), the nation’s largest health insurer, has...
Due to their high-entropy nature, I’m not the biggest fan of specialized healthcare enterprises. With Exact Sciences (NASDAQ:EXAS) straddling the...
When it comes to top-trending stocks, the general rule of thumb is that whatever news that moved the securities in question is fully baked in. Quite...
Verona Pharma (NASDAQ:VRNA) jumped over 20% after Merck (NYSE:MRK) announced it was buying the company for $10 billion, or $107 per American...
When it comes to equity market losers — I’m talking massive hemorrhaging in the charts — it’s hard not to think about Centene (NYSE:CNC)....
While Monday was a rough one for Wall Street, opportunistic traders may be eyeballing potentially compelling discounts. One name to keep in mind is...
While the market suffered a rough outing on Monday, opportunistic traders may be on the prowl for intriguing names on discount. To be sure, you can...
Typically, the MO of the financial publication industry is to pick an enterprise generating headlines, present an opinion about it and provide a bull...